300937.SZ
药易购
SZSE · F 批发零售 · CN
CNY 25.16
−3.68%Year over year
Reported trailing growth
- Revenue
- +3.2%
- EBITDA
- —
- EBIT
- -38.6%
- EPS
- —
- Free cash flow
- -90.2%
- Operating cash flow
- -87.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.9%
- EBITDA
- -17.3%
- EBIT
- -42.6%
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026